科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/25 | 3,901 | 3,908 | 3,870 | 3,900 | +15 | +0.4% | 160,800 |
| 2024/10/24 | 3,852 | 3,899 | 3,840 | 3,885 | +31 | +0.8% | 79,800 |
| 2024/10/23 | 3,848 | 3,892 | 3,840 | 3,854 | -11 | -0.3% | 93,200 |
| 2024/10/22 | 3,870 | 3,872 | 3,833 | 3,865 | -4 | -0.1% | 88,100 |
| 2024/10/21 | 3,861 | 3,871 | 3,838 | 3,869 | +5 | +0.1% | 99,900 |
| 2024/10/18 | 3,889 | 3,922 | 3,853 | 3,864 | +13 | +0.3% | 95,900 |
| 2024/10/17 | 3,842 | 3,859 | 3,827 | 3,851 | +17 | +0.4% | 84,700 |
| 2024/10/16 | 3,869 | 3,907 | 3,834 | 3,834 | -72 | -1.8% | 73,100 |
| 2024/10/15 | 3,881 | 3,907 | 3,865 | 3,906 | +25 | +0.6% | 109,200 |
| 2024/10/11 | 3,900 | 3,905 | 3,873 | 3,881 | -19 | -0.5% | 84,900 |
| 2024/10/10 | 3,880 | 3,914 | 3,880 | 3,900 | -3 | -0.1% | 60,700 |
| 2024/10/09 | 3,885 | 3,911 | 3,874 | 3,903 | +36 | +0.9% | 87,600 |
| 2024/10/08 | 3,850 | 3,891 | 3,839 | 3,867 | -12 | -0.3% | 100,900 |
| 2024/10/07 | 3,890 | 3,890 | 3,851 | 3,879 | +19 | +0.5% | 112,500 |
| 2024/10/04 | 3,840 | 3,875 | 3,840 | 3,860 | -8 | -0.2% | 88,000 |
| 2024/10/03 | 3,863 | 3,879 | 3,831 | 3,868 | +52 | +1.4% | 126,000 |
| 2024/10/02 | 3,827 | 3,870 | 3,812 | 3,816 | -19 | -0.5% | 83,300 |
| 2024/10/01 | 3,823 | 3,846 | 3,776 | 3,835 | +12 | +0.3% | 82,500 |
| 2024/09/30 | 3,779 | 3,837 | 3,770 | 3,823 | -26 | -0.7% | 94,200 |
| 2024/09/27 | 3,880 | 3,895 | 3,840 | 3,849 | -158 | -3.9% | 144,400 |
| 2024/09/26 | 3,980 | 4,007 | 3,968 | 4,007 | +47 | +1.2% | 139,700 |
| 2024/09/25 | 3,916 | 3,970 | 3,899 | 3,960 | +43 | +1.1% | 93,100 |
| 2024/09/24 | 3,949 | 3,957 | 3,908 | 3,917 | -19 | -0.5% | 108,200 |
| 2024/09/20 | 3,904 | 3,960 | 3,904 | 3,936 | +35 | +0.9% | 140,900 |
| 2024/09/19 | 3,910 | 3,952 | 3,901 | 3,901 | -14 | -0.4% | 84,900 |
| 2024/09/18 | 3,910 | 3,946 | 3,882 | 3,915 | -8 | -0.2% | 81,800 |
| 2024/09/17 | 3,965 | 3,974 | 3,893 | 3,923 | -4 | -0.1% | 95,200 |
| 2024/09/13 | 3,958 | 3,958 | 3,900 | 3,927 | -64 | -1.6% | 107,600 |
| 2024/09/12 | 4,000 | 4,033 | 3,967 | 3,991 | +1 | ±0% | 86,700 |
| 2024/09/11 | 4,011 | 4,052 | 3,965 | 3,990 | -44 | -1.1% | 110,700 |
| 2024/09/10 | 4,011 | 4,054 | 4,011 | 4,034 | -11 | -0.3% | 61,800 |
| 2024/09/09 | 4,014 | 4,063 | 4,008 | 4,045 | -18 | -0.4% | 70,100 |
| 2024/09/06 | 4,098 | 4,109 | 4,057 | 4,063 | +6 | +0.1% | 104,400 |
| 2024/09/05 | 4,070 | 4,094 | 4,039 | 4,057 | -20 | -0.5% | 73,800 |
| 2024/09/04 | 4,028 | 4,092 | 4,028 | 4,077 | +39 | +1% | 127,400 |
| 2024/09/03 | 4,025 | 4,051 | 4,000 | 4,038 | +26 | +0.6% | 67,700 |
| 2024/09/02 | 4,128 | 4,128 | 4,009 | 4,012 | -116 | -2.8% | 111,900 |
| 2024/08/30 | 4,108 | 4,130 | 4,078 | 4,128 | +28 | +0.7% | 184,400 |
| 2024/08/29 | 4,119 | 4,141 | 4,074 | 4,100 | -13 | -0.3% | 95,100 |
| 2024/08/28 | 4,111 | 4,124 | 4,088 | 4,113 | +5 | +0.1% | 88,300 |
| 2024/08/27 | 4,087 | 4,112 | 4,083 | 4,108 | +41 | +1% | 83,100 |
| 2024/08/26 | 4,095 | 4,099 | 4,049 | 4,067 | -46 | -1.1% | 82,600 |
| 2024/08/23 | 4,110 | 4,135 | 4,098 | 4,113 | +12 | +0.3% | 105,500 |
| 2024/08/22 | 4,100 | 4,154 | 4,090 | 4,101 | +5 | +0.1% | 112,700 |
| 2024/08/21 | 3,970 | 4,100 | 3,934 | 4,096 | +119 | +3% | 180,900 |
| 2024/08/20 | 3,971 | 3,989 | 3,942 | 3,977 | +58 | +1.5% | 133,000 |
| 2024/08/19 | 3,974 | 3,974 | 3,900 | 3,919 | -32 | -0.8% | 80,400 |
| 2024/08/16 | 3,920 | 3,952 | 3,884 | 3,951 | +72 | +1.9% | 131,600 |
| 2024/08/15 | 3,944 | 3,944 | 3,855 | 3,879 | -28 | -0.7% | 105,900 |
| 2024/08/14 | 3,841 | 3,928 | 3,821 | 3,907 | +66 | +1.7% | 118,600 |
201～
250
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 250,600円 | - | - | 0.00% | - | 116.07倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 297,400円 | +7.9% | -3.3% | 2.69% | 8.27倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 267,800円 | +21.7% | +999.9% | 0.00% | 12.34倍 | 4.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
